| Literature DB >> 32376478 |
Masumi Katane1, Hisashi Kuwabara1, Kazuki Nakayama1, Yasuaki Saitoh1, Tetsuya Miyamoto1, Masae Sekine1, Hiroshi Homma2.
Abstract
d-Aspartate oxidase (DDO) is a flavin adenine dinucleotide (FAD)-containing flavoprotein that stereospecifically acts on acidic d-amino acids (i.e., free d-aspartate and d-glutamate). Mammalian DDO, which exhibits higher activity toward d-aspartate than d-glutamate, is presumed to regulate levels of d-aspartate in the body and is not thought to degrade d-glutamate in vivo. By contrast, three DDO isoforms are present in the nematode Caenorhabditis elegans, DDO-1, DDO-2, and DDO-3, all of which exhibit substantial activity toward d-glutamate as well as d-aspartate. In this study, we optimized the Escherichia coli culture conditions for production of recombinant C. elegans DDO-1, purified the protein, and showed that it is a flavoprotein with a noncovalently but tightly attached FAD. Furthermore, C. elegans DDO-1, but not mammalian (rat) DDO, efficiently and selectively degraded d-glutamate in addition to d-aspartate, even in the presence of various other amino acids. Thus, C. elegans DDO-1 might be a useful tool for determining these acidic d-amino acids in biological samples.Entities:
Keywords: Caenorhabditis elegans; Enzymatic method; d-Amino acid; d-Aspartate oxidase; d-Glutamate; d-Glutamate cyclase
Year: 2020 PMID: 32376478 DOI: 10.1016/j.bbapap.2020.140442
Source DB: PubMed Journal: Biochim Biophys Acta Proteins Proteom ISSN: 1570-9639 Impact factor: 3.036